weight loss medication retatrutide Retatrutide: The New Triple-Agonist Treatment A New Obesity Drug Delivered

When GLP-1 receptors activate, they slow gastric emptying

Begin by washing your hands and sanitizing the injection site Use a new needle (Ozempic) or a new injection pen (Wegovy)

This is the first phase 3 readout of that triple mechanism specifically in a type 2 diabetes population rather than obesity alone, and the glycemic effect size is notable relative to existing incretin based therapies

The main types are: Unstable Angina (UA): Caused by partial rupture/occlusion of a coronary artery

Choosing larger bundles provides greater value, particularly for those who plan to eat multiple dishes per day

The most common side effects associated with GLP-1 agonists include appetite loss, nausea, vomiting, and diarrhea, which are often more pronounced when starting the medication or increasing the dosage (4)(10)(23)